Literature DB >> 10352391

Onapristone suppresses prolactin production in explant cultures of leiomyoma.

D J Austin1, R A Nowak, E A Stewart.   

Abstract

OBJECTIVE: To assess the action of onapristone, a type I antiprogestin, on prolactin (PRL) production by explant cultures of leiomyoma and myometrium.
DESIGN: Explant cultures of myometrium and leiomyomas from 3 premenopausal women undergoing hysterectomy in the proliferative phase of the menstrual cycle. MAIN OUTCOME MEASURES: PRL secretion measured by radioimmunoassay.
RESULTS: PRL secretion was decreased in leiomyomas by onapristone. There was no effect in the myometrium. There was no additional effect with the addition of the type II antiprogestin mifepristone (RU 486).
CONCLUSION: PRL production is suppressed in leiomyomas but not in myometrium after treatment with onapristone in vitro. This suppression may serve as a marker for the clinical effectiveness of agents used in the treatment of leiomyomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10352391     DOI: 10.1159/000010120

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  2 in total

1.  Predisposing factors for fibroids and outcome of laparoscopic myomectomy in infertility.

Authors:  Prakash Trivedi; Mohini Abreo
Journal:  J Gynecol Endosc Surg       Date:  2009-01

Review 2.  Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction.

Authors:  Andrea Ciavattini; Jacopo Di Giuseppe; Piergiorgio Stortoni; Nina Montik; Stefano R Giannubilo; Pietro Litta; Md Soriful Islam; Andrea L Tranquilli; Fernando M Reis; Pasquapina Ciarmela
Journal:  Obstet Gynecol Int       Date:  2013-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.